Everhart Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Sell
5,085
-224
-4% -$76.7K 0.12% 89
2026
Q1
$1.87M Buy
5,309
+992
+23% +$354K 0.16% 86
2025
Q4
$1.41M Buy
4,317
+241
+6% +$76.4K 0.13% 102
2025
Q3
$1.15M Buy
4,076
+117
+3% +$33.9K 0.12% 123
2025
Q2
$1.11M Buy
3,959
+209
+6% +$59.2K 0.13% 110
2025
Q1
$1.17M Buy
3,750
+1,795
+92% +$530K 0.16% 89
2024
Q4
$510K Sell
1,955
-1,633
-46% -$485K 0.1% 184
2024
Q3
$1.16M Buy
3,588
+544
+18% +$178K 0.26% 80
2024
Q2
$951K Buy
3,044
+984
+48% +$289K 0.25% 77
2024
Q1
$586K Buy
2,060
+232
+13% +$67.9K 0.17% 125
2023
Q4
$527K Buy
1,828
+214
+13% +$58.3K 0.19% 108
2023
Q3
$434K Buy
1,614
+409
+34% +$102K 0.18% 106
2023
Q2
$268K Sell
1,205
-25
-2% -$5.8K 0.11% 172
2023
Q1
$297K Sell
1,230
-780
-39% -$191K 0.13% 137
2022
Q4
$528K Buy
2,010
+221
+12% +$59.2K 0.27% 82
2022
Q3
$403K Buy
1,789
+70
+4% +$17K 0.22% 88
2022
Q2
$418K Buy
+1,719
New +$421K 0.25% 91

Other funds holding AMGN

Everhart Financial Group's AMGN Position: Q2 2026 in Review

Everhart Financial Group reduced its Amgen (AMGN) stake by 4.2% in Q2 2026, selling an estimated $76.7K and leaving 5,085 shares worth $1.84M. The position accounts for 0.12% of the portfolio, ranked #89.

Everhart Financial Group first reported a position in AMGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.87M in Q1 2026. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Everhart Financial Group held 5,085 shares of Amgen worth $1.84M as of Q2 2026.
  • Everhart Financial Group sold 224 Amgen shares in Q2 2026, an estimated $76.7K.
  • Amgen made up 0.12% of Everhart Financial Group's portfolio in Q2 2026, its #89 holding.
  • Everhart Financial Group first reported a position in Amgen in Q2 2022 and has held it in 17 quarters since.
  • Everhart Financial Group's Amgen position peaked at $1.87M in Q1 2026.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.